A customizable multiplex protein microarray for antibody testing and its application for tick-borne and other infectious diseases

Competing Interest Statement

The authors have read the journal's policy and the authors of this manuscript have the following competing interests. CS and SM are paid employees of Vibrant America LLC. KK, VJ, TW, KB, HKK, and JJR are paid employees of Vibrant Sciences LLC. he other authors are academic collaborators who provided samples and assisted in the review and editing of the manuscript. AJR is a paid consultant of Vibrant America LLC. Vibrant America offers commercial testing for Lyme disease and other infectious diseases and could benefit from increased testing.

Funding Statement

Vibrant America provided funding for this study in the form of salaries for authors [CS, SM, KK, VJ, TW, KB, HKK, JJR]. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Internal Review Board (AKBE/24/16) of the Warsaw Medical University gave approval for this work. WCG IRB #1-1574995-1 of WCGIRB waived ethical approval for this work. Schulman IRB # 201700960, #201607925 of Schulman IRB gave ethical approval for this work. 17-00013 (WCMC-Q) and QU-IRB 518-EA/15 of Qatar University gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes